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Abstract
There is paucity of literature regarding the anaesthetic
management of patients with thalassaemia intermedia. In this
case study, the anaesthetic management and concerns in two
children with thalassaemia intermedia aged eleven and nine
years undergoing herniotomy and splenectomy respectively
is reported. Both children had unanticipated difficulty in
airway management and high intraoperative blood pressure
trends. These cases are representative of the range of
problems seen in children with thalassaemia intermedia. 
Introduction
Thalassaemias are hereditary disorders characterized
by reduction in the synthesis of globin chains (α or β) in the
haemoglobin (Hb) molecules. This reduction in synthesis of
haemoglobin produces hypochromic microcytic anaemia.
Normal adult haemoglobin is primarily haemoglobin A
(HbA). In  β-thalassaemia, reduced β-globin chain synthesis
results in a relative increase in the percentages of Hb A2 and
F compared to Hb A. Patients homozygous for a milder form
of β-thalassaemia have thalassaemia intermedia.
Genotypically they have Hb A value of 0-30%, Hb A2 0-10%
and Hb F 6-100%. These patients have chronic haemolytic
anaemia but do not require transfusions except under periods
of stress. If transfusion requirement is high they may also
develop iron overload. They survive into adult life but with
hepatosplenomegaly and bony deformities.1
Literature on anaesthetic management of thalassaemia
exists but we were unable to locate any specific case reports
of anaesthetic management of children with thalassaemia
intermedia. We report the management of two cases with β-
thalassaemia intermedia and review of literature on the
anaesthetic concerns associated with this disease.
Case Reports
An eleven years old female child presented for
bilateral inguinal hernia repair. On preoperative examination
the patient had frontal bossing and tonsillar enlargement. Her
airway was assessed and found normal. Her haemoglobin and
haemotocrit were 9.1 gm.dl-1 and 28.1% respectively. Hb A2
was 2.4% and Hb F was 97.6%. She had never been
transfused.
Midazolam 5mg was used as premedication.
Monitoring included pulse oximeter, non-invasive blood
pressure (NIBP), ECG and capnography (ETCO2). Patient
was induced with sevoflurane and oxygen. Pethidine 0.8
mg.kg-1 was used as an analgesic. An attempt was made to
insert size 2 laryngeal mask airway (LMA) but difficulty in
placement was encountered due to a high arched palate.
Patient's trachea was then intubated with a size 5.5 mm
endotracheal tube after administration of atracurium.
Intubation grade was Modified Cormack and Lehane IIb.
Anaesthesia was maintained with O2:N2O 1:1, isoflurane at 1
MAC (Minimum Alveolar Concentration) and bolus doses of
atracurium. ETCO2 was within normal limits. Baseline heart
rate was 120 beats.minute-1 and it was maintained between
120-130 beats.minute-1, blood pressures showed a trend
towards hypertension intra-operatively with systolic blood
pressure around 130 mmHg (baseline 90 mmHg) and
diastolic blood pressure 80-90 (baseline 40) mmHg.
Anaesthesia and surgery lasted for 90 minutes. Two hundred
milliliters of crystalloid solution was administered. Recovery
and postoperative periods were uneventful. 
Second patient was a nine years old male child, a
known case of thalassaemia intermedia who presented for
elective splenectomy. Splenectomy was scheduled to reduce
blood transufusion requirements as patient was being
transfused with one unit of packed cell every month for last
four years. Preoperatively airway was assessed as normal.
Patient had a haemoglobin value of 8.7 gm.dl-1, haematocrit
of 25.1%, with HbA2 1.5% and HbF 98.5%. ECG revealed a
heart rate of 91 beats.minute-1, and left vertricular
hypertrophy with T wave inversion in V1-V3. 
Child was premedicated with midazolam. Monitors
used were pulse oximeter, noninvasive blood pressure
(NIBP), ECG and capnograph. Induction was achieved with
thiopentone 5mg.kg-1, fentanyl 2ug.kg-1 and atracurium
0.5mg.kg-1. On direct laryngoscopy, Cormack Lehane grade
was found to be IIb. Intubation was done with the help of a
stylet. Patient was then ventilated with O2:N20 ratio of 1:1.
ETCO2 was maintained within normal limits. Baseline heart
rate was 100 beats.minute-1 and was maintained between
100-115 beats.minute-1. Blood pressures in the beginning
were 90/40 mm Hg and remained in the range of 100-110 mm
Hg systolic blood pressure and 60-70 mm Hg diastolic blood
pressure inspite of analgesia. Blood loss was minimal.
Surgery lasted for 150 minutes. Three hundred and fifty
milliliters of crystalloid solution was administered.
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Extubation and postoperative periods were uneventful. 
Discussion
β-thalassaemia primarily affect persons from
Mediterranean origin and to a lesser extent Chinese, other
Asians, and blacks.1 In Pakistan, thalassaemia is the most
prevalent genetically transmitted blood disorder with a carrier
rate of 5-8%; around 5000 children are diagnosed each year
in the country.2
Kitoh et al reported the management of an adult
patient with thalassaemia intermedia and haemolytic crisis
that underwent splenectomy.3 Patient had hyperkinetic left
ventricular motion and increased cardiac index. This patient
was successfully managed using isoflurane at low
concentration and fentanyl. In another case report successful
management of an adult patient with thalassaemia intermedia
and severe haemolytic anaemia undergoing emergency
splenectomy was discussed.4
Patients with β-thalassaemia intermedia generally do
not require blood transfusions. But if the presentation of the
disease is severe and these patients are not adequately
transfused; marked medullary expansion,
hepatosplenomegaly, growth retardation, facial anomalies,
and hyperbilirubinaemia may occur.5 Extra-medullary
haematopoieses can occur in the vertebral canal, compressing
the spinal cord and causing neurologic symptoms. These
patients may present with nutritional haemosideroses (if
transfused) and other complications of thalassaemia.6
There are several anaesthetic implications of β-
thalassaemia.7 Patients with  -thalassaemia intermedia can
also present with these difficulties if the disease is severe
and/or the treatment is delayed. Extra medullary
haematopoises resulting in maxillary bone enlargement can
make airway management difficult. If patients are on regular
transfusions, preoperative evaluation should focus on those
organs most affected by haemochromatosis: the heart,
endocrine system, and liver. There is also a high incidence of
blood transfusion related diseases like hepatitis; hence
precautions must be taken to avoid exposure to blood and
body fluids. The incidence of RBC alloimmunization in
children with thalassaemia is approximately 5%, making
provision of compatible blood a potential problem.
Preoperative transfusion to adequate levels should be
performed. Hypoxia, cardiovascular depression and
haemoglobinuria should be avoided peri-operatively. 
In our cases, the first child was not transfusion
dependent and had no specific features of blood transfusions
and thalassemic children except for anaemia and frontal
bossing. The problems encountered were difficulty in LMA
placement and a slight difficulty in tracheal tube insertion
along with trend towards intra-operative hypertension. The
second case was representative of a more severe form of
thalassaemia intermedia had a history of monthly blood
transfusions for last four years along with frontal and
maxillary bossing. He did have abnormal liver function tests
and signs of myocardial strain. He also had Cormack and
Lehane IIb intubation and his blood pressure also showed a
trend towards higher side. Variations in facial bone anatomy
in thalassaemic children is thought to be the cause of difficult
airway in these children. These two cases elicit the variation
in symptoms and signs observed in this disease of which
anaesthetists need to be aware about.
One retrospective study of 100 thalassaemic children
undergoing splenectomy reported intraoperative and
postoperative hypertension requiring aggressive treatment.
The authors suggested manipulation of the large spleen
during surgical removal resulting in autotransfusion as a
possible cause of hypertension.8 In another study of
thalassaemic children undergoing splenectomy, furosemide
decreased the incidence of postoperative convulsions but had
no significant effect on the incidence of postoperative
hypertension.9
Slight difficulty in managing the airway can be
explained by facial anomalies that develop in this group of
patients. Repetitive blood transfusions throughout the life and
autotransfusion during splenectomy are considered as
possible causes of increased blood pressure. We were unable
to find a satisfactory explanation for isolated intraoperative
hypertension in both cases despite analgesia and adequate
depth of anaesthesia. There is scarcity of information about
this group of thalassaemic patients undergoing anaesthesia
and surgery, and more published literature is needed to make
further guidelines.
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